guest ::
| Home > Publications database > An Ustilago maydis chassis for itaconic acid production without by‐products > print |
| Home > Publications database > An Ustilago maydis chassis for itaconic acid production without by‐products > print |
| 001 | 872541 | ||
| 005 | 20230117082039.0 | ||
| 024 | 7 | _ | |a 10.1111/1751-7915.13525 |2 doi |
| 024 | 7 | _ | |a 1751-7907 |2 ISSN |
| 024 | 7 | _ | |a 1751-7915 |2 ISSN |
| 024 | 7 | _ | |a 2128/24433 |2 Handle |
| 024 | 7 | _ | |a altmetric:73781372 |2 altmetric |
| 024 | 7 | _ | |a pmid:31880860 |2 pmid |
| 024 | 7 | _ | |a WOS:000504538600001 |2 WOS |
| 037 | _ | _ | |a FZJ-2020-00059 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Becker, Johanna |0 0000-0001-9998-1846 |b 0 |
| 245 | _ | _ | |a An Ustilago maydis chassis for itaconic acid production without by‐products |
| 260 | _ | _ | |a Oxford |c 2020 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1583158631_24314 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a Biotechnologie 1 |
| 520 | _ | _ | |a Ustilago maydis is a promising yeast for the production of a range of valuable metabolites, including itaconate, malate, glycolipids and triacylglycerols. However, wild‐type strains generally produce a potpourri of all of these metabolites, which hinders efficient production of single target chemicals. In this study, the diverse by‐product spectrum of U. maydis was reduced through strain engineering using CRISPR/Cas9 and FLP/FRT, greatly increasing the metabolic flux into the targeted itaconate biosynthesis pathway. With this strategy, a marker‐free chassis strain could be engineered, which produces itaconate from glucose with significantly enhanced titre, rate and yield. The lack of by‐product formation not only benefited itaconate production, it also increases the efficiency of downstream processing improving cell handling and product purity. |
| 536 | _ | _ | |a 581 - Biotechnology (POF3-581) |0 G:(DE-HGF)POF3-581 |c POF3-581 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Hosseinpour Tehrani, Hamed |0 P:(DE-Juel1)176855 |b 1 |
| 700 | 1 | _ | |a Gauert, Marc |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Mampel, Jörg |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Blank, Lars M. |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Wierckx, Nick |0 P:(DE-Juel1)176653 |b 5 |e Corresponding author |
| 773 | _ | _ | |a 10.1111/1751-7915.13525 |g p. 1751-7915.13525 |0 PERI:(DE-600)2406063-X |n 2 |p 350 - 362 |t Microbial biotechnology |v 13 |y 2020 |x 1751-7915 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/872541/files/Rechnung_R-2019-00444.pdf |
| 856 | 4 | _ | |y OpenAccess |u https://juser.fz-juelich.de/record/872541/files/Becker%20et%20al%202019%20Microb%20Biotechnol%201-13.pdf |
| 856 | 4 | _ | |x pdfa |u https://juser.fz-juelich.de/record/872541/files/Rechnung_R-2019-00444.pdf?subformat=pdfa |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://juser.fz-juelich.de/record/872541/files/Becker%20et%20al%202019%20Microb%20Biotechnol%201-13.pdf?subformat=pdfa |
| 909 | C | O | |o oai:juser.fz-juelich.de:872541 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-Juel1)176653 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Key Technologies for the Bioeconomy |1 G:(DE-HGF)POF3-580 |0 G:(DE-HGF)POF3-581 |2 G:(DE-HGF)POF3-500 |v Biotechnology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MICROB BIOTECHNOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DOAJ Journal |2 APC |0 PC:(DE-HGF)0003 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)IBG-1-20101118 |k IBG-1 |l Biotechnologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)IBG-1-20101118 |
| 980 | _ | _ | |a APC |
| 980 | 1 | _ | |a APC |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|